Not Yet Recruiting
Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy
NCT07197112
- Conditions
- Acute Graft Versus Host Disease Grade II-IV, Acute Graft vs Host Disease
- Locations
-
Not specified